Literature DB >> 24257616

ISG15 is counteracted by vaccinia virus E3 protein and controls the proinflammatory response against viral infection.

Benedito Eduardo-Correia1, Carles Martínez-Romero, Adolfo García-Sastre, Susana Guerra.   

Abstract

Conjugation of ISG15 inhibits replication of several viruses. Here, using an expression system for assaying human and mouse ISG15 conjugations (ISGylations), we have demonstrated that vaccinia virus E3 protein binds and antagonizes human and mouse ISG15 modification. To study ISGylation importance in poxvirus infection, we used a mouse model that expresses deconjugating proteases. Our results indicate that ISGylation restricts in vitro replication of the vaccinia virus VVΔE3L mutant but unconjugated ISG15 is crucial to counteract the inflammatory response produced after VVΔE3L infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24257616      PMCID: PMC3911545          DOI: 10.1128/JVI.03293-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Host response to the attenuated poxvirus vector NYVAC: upregulation of apoptotic genes and NF-kappaB-responsive genes in infected HeLa cells.

Authors:  Susana Guerra; Luis A López-Fernández; Alberto Pascual-Montano; José Luis Nájera; Angel Zaballos; Mariano Esteban
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme.

Authors:  C Rivas; J Gil; Z Mĕlková; M Esteban; M Díaz-Guerra
Journal:  Virology       Date:  1998-04-10       Impact factor: 3.616

3.  ISG15 modification of ubiquitin E2 Ubc13 disrupts its ability to form thioester bond with ubiquitin.

Authors:  Weiguo Zou; Vladimir Papov; Oxana Malakhova; Keun Il Kim; Chinh Dao; Jun Li; Dong-Er Zhang
Journal:  Biochem Biophys Res Commun       Date:  2005-10-14       Impact factor: 3.575

4.  Microarray analysis reveals characteristic changes of host cell gene expression in response to attenuated modified vaccinia virus Ankara infection of human HeLa cells.

Authors:  Susana Guerra; Luis A López-Fernández; Raquel Conde; Alberto Pascual-Montano; Keith Harshman; Mariano Esteban
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

5.  The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein.

Authors:  Chen Zhao; Sylvie L Beaudenon; Melissa L Kelley; M Brett Waddell; Weiming Yuan; Brenda A Schulman; Jon M Huibregtse; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-06       Impact factor: 11.205

6.  Species specificity of the NS1 protein of influenza B virus: NS1 binds only human and non-human primate ubiquitin-like ISG15 proteins.

Authors:  Haripriya Sridharan; Chen Zhao; Robert M Krug
Journal:  J Biol Chem       Date:  2010-01-21       Impact factor: 5.157

7.  Cellular gene expression survey of vaccinia virus infection of human HeLa cells.

Authors:  Susana Guerra; Luis A López-Fernández; Alberto Pascual-Montano; Manuel Muñoz; Keith Harshman; Mariano Esteban
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency.

Authors:  Dusan Bogunovic; Minji Byun; Larissa A Durfee; Avinash Abhyankar; Ozden Sanal; Davood Mansouri; Sandra Salem; Irena Radovanovic; Audrey V Grant; Parisa Adimi; Nahal Mansouri; Satoshi Okada; Vanessa L Bryant; Xiao-Fei Kong; Alexandra Kreins; Marcela Moncada Velez; Bertrand Boisson; Soheila Khalilzadeh; Ugur Ozcelik; Ilad Alavi Darazam; John W Schoggins; Charles M Rice; Saleh Al-Muhsen; Marcel Behr; Guillaume Vogt; Anne Puel; Jacinta Bustamante; Philippe Gros; Jon M Huibregtse; Laurent Abel; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova
Journal:  Science       Date:  2012-08-02       Impact factor: 47.728

9.  Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation.

Authors:  Min-Jung Kim; Sun-Young Hwang; Tadaatsu Imaizumi; Joo-Yeon Yoo
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

10.  Antiviral Properties of ISG15.

Authors:  Deborah J Lenschow
Journal:  Viruses       Date:  2010-09-28       Impact factor: 5.818

View more
  15 in total

1.  Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance.

Authors:  Lars Ketscher; Ronny Hannß; David J Morales; Anja Basters; Susana Guerra; Tobias Goldmann; Annika Hausmann; Marco Prinz; Ronald Naumann; Andrew Pekosz; Olaf Utermöhlen; Deborah J Lenschow; Klaus-Peter Knobeloch
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

2.  Mutational analysis of vaccinia virus E3 protein: the biological functions do not correlate with its biochemical capacity to bind double-stranded RNA.

Authors:  Kevin J Dueck; YuanShen Sandy Hu; Peter Chen; Yvon Deschambault; Jocelyn Lee; Jessie Varga; Jingxin Cao
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

Review 3.  Innate Antiviral Immunity in the Skin.

Authors:  Chelsea Handfield; Jeffery Kwock; Amanda S MacLeod
Journal:  Trends Immunol       Date:  2018-03-08       Impact factor: 16.687

4.  Regulation of PACT-Mediated Protein Kinase Activation by the OV20.0 Protein of Orf Virus.

Authors:  Yeu-Yang Tseng; Guan-Ru Liao; Ganes C Sen; Fong-Yuan Lin; Wei-Li Hsu
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

5.  Vaccinia Virus C9 Ankyrin Repeat/F-Box Protein Is a Newly Identified Antagonist of the Type I Interferon-Induced Antiviral State.

Authors:  Ruikang Liu; Bernard Moss
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

6.  Human Cytomegalovirus pTRS1 and pIRS1 Antagonize Protein Kinase R To Facilitate Virus Replication.

Authors:  Benjamin Ziehr; Heather A Vincent; Nathaniel J Moorman
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

7.  ISG15 Is Upregulated in Respiratory Syncytial Virus Infection and Reduces Virus Growth through Protein ISGylation.

Authors:  Rubén González-Sanz; Manuel Mata; Jesús Bermejo-Martín; Amparo Álvarez; Julio Cortijo; José A Melero; Isidoro Martínez
Journal:  J Virol       Date:  2016-01-13       Impact factor: 5.103

8.  ISG15 silencing increases cisplatin resistance via activating p53-mediated cell DNA repair.

Authors:  Yi Huo; Zhaoyun Zong; Qingtao Wang; Zhenyu Zhang; Haiteng Deng
Journal:  Oncotarget       Date:  2017-11-18

Review 9.  HERC5 and the ISGylation Pathway: Critical Modulators of the Antiviral Immune Response.

Authors:  Nicholas A Mathieu; Ermela Paparisto; Stephen D Barr; Donald E Spratt
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.048

10.  ISG15 deficiency and increased viral resistance in humans but not mice.

Authors:  Scott D Speer; Zhi Li; Sofija Buta; Béatrice Payelle-Brogard; Li Qian; Frederic Vigant; Erminia Rubino; Thomas J Gardner; Tim Wedeking; Mark Hermann; James Duehr; Ozden Sanal; Ilhan Tezcan; Nahal Mansouri; Payam Tabarsi; Davood Mansouri; Véronique Francois-Newton; Coralie F Daussy; Marisela R Rodriguez; Deborah J Lenschow; Alexander N Freiberg; Domenico Tortorella; Jacob Piehler; Benhur Lee; Adolfo García-Sastre; Sandra Pellegrini; Dusan Bogunovic
Journal:  Nat Commun       Date:  2016-05-19       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.